Kinase inhibitor combination combats liver cancer
- PMID: 34344998
- DOI: 10.1038/d41573-021-00132-5
Kinase inhibitor combination combats liver cancer
Comment on
-
EGFR activation limits the response of liver cancer to lenvatinib.Nature. 2021 Jul;595(7869):730-734. doi: 10.1038/s41586-021-03741-7. Epub 2021 Jul 21. Nature. 2021. PMID: 34290403
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
